U.S. Markets open in 27 hrs, 57 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 11,220.96 | 32.73 | 0.29% |
| NASDAQ | 2,255.88 | -3.16 | -0.14% |
| S&P 500 | 1,242.31 | 5.48 | 0.44% |
| Day Low 11:06 AM EDT | 6.36 | |
|---|---|---|
| Day High 03:51 PM EDT | 6.77 |
|
| Range | 0.41 | |
| Volume | 2.6 M | |
| 30-Day Avg. Vol. | 1.77 M |
|
| Difference | 46.50% | |
| Market Cap. | 908.17 M | |
| Change | 13.55 M | |
| Shares Out. | 135.54 M | |
| Percent Traded | 1.92% | |
| Revenue (LFY) | 41.85 M | |
| Earnings (TTM) | -262.44 M | |
| Next Earnings | 9/4/08 |
|
| EPS (TTM) | -2.09 |
| 52-Wk Low 3/11/08 | 4.74 | |
|---|---|---|
| 52-Wk High 1/4/08 | 11.95 |
|
| Range | 7.21 | |
| Prev. Close 9/4/08 | 6.60 | |
| Today's Open | 6.58 | |
| Change | -0.30% | |
| Dividend (TTM) | 0.00 | |
| Div. Yield (TTM) | 0.00% |
|
| Beta | 2.2885 | |
| P/E Ratio (TTM) | — | |
| P/E Ratio (Fwd.) | — |
Human Genome Sciences (HGS) knows that the fault lies within ourselves, not in the stars. Using its expertise in human genetics, the firm is working on therapies for infectious and autoimmune diseases ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| 2 Quarters Ago | -0.189 3/31/08 | -0.35 3/31/08 |
-0.161
Missed
|
| Last Quarter | -0.544 6/30/08 | -0.55 6/30/08 |
-0.006
Missed
|
| Quarterly - 06/30/2008 | Annual - 2007 | |
|---|---|---|
| Total Revenue | 11.57 M | 41.85 M |
| Gross Profit | -61.08 M | -203.89 M |
| Operating Income | -70.22 M | -259.77 M |
| Net Income | -74.19 M | -262.45 M |
